Join us at AHA 2026
Heartflow Plaque Staging is helping clinicians move beyond traditional risk calculators toward a more personalized, patient-specific approach to managing CAD.
Join us as we share 1-year outcome evidence from the DECIDE study and the LIFE-AI late breaking clinical science presentations, both to be presented for the first time at this year's Scientific Sessions. Hear directly from leading cardiologists at our Heart Theater session, and get hands-on experience in the Simulation Zone.
New Clinical Data Presented at AHA 2026
Real-world Evidence from DECIDE: 1-Year Outcomes
Rethinking Image and ECG Processing and AI - Reducing Clinic Burden in Imaging through Machine Automation
Date & Time: Monday, November 9
10:45am-12:00pm (CST)
Location: Moderated Digital Poster 21, Population Science Zone
Presentation: Artificial Intelligence-Enabled Coronary Plaque Analysis Improves Medical Management and Clinical Outcomes Compared to Coronary Computed Tomographic Angiography: Insights from the DECIDE Registry
Presented by: Leslee Shaw, PhD
11:06-11:11am
Late-breaking Science
Artificial Intelligence in the Diagnosis of Cardiovascular Disease
Date & Time: Monday, November 9
9:45-11:00am (CST)
Location: Center Stage, North Hall, Level 3
Presentation: All-Cause and Cardiovascular Mortality in the U.S.: Risk Stratification via Integrated AI-Enabled Coronary Plaque Analysis and FFRCt in Over 269,000 Patients
Presented by: Ankitkumar Patel, MD
10:32-10:42am
GAMEFILM Registry
Lifestyle Determinants of Cardiovascular Risk: From Exposures to Rehabilitation
Date & Time: Monday, November 9
9:15-10:30am (CST)
Location: Moderated Digital Poster 22, Population Science Zone
Presentation: High Coronary Atherosclerosis Burden in Retired NFL Players: The GAMEFILM Registry.
Ways to Connect with Us
Visit Us at Booth #711, Exhibit Hall
Live, engaging demos of Plaque Analysis and FFRCT. Take the DECIDE challenge for yourself and get to know David as Heartflow knows David.
Attend Expert Theater
Sun, Nov 8, 3:15-4:00pm, Heart Theater 1
Education session on personalized CAD risk assessment and plaque staging.
Try the Simulation Zone
Hands-on, interactive CCTA testing experience with the Heartflow platform open across all three days.
Book a VIP Meeting
Business Suite B45
Meet with our leadership team to discuss your top priorities. Contact your local account manager or click below to request a meeting.
Explore the Innovation Hub
In-booth area previewing emerging, next generation technology in risk stratification and plaque tracking capabilities.
Personalized CAD Risk Assessment and Plaque Staging with the CCTA + Heartflow Platform
Sunday, Nov 8 | 3:15-4:00pm
Heart Theater 1
This session explores how CCTA with AI-enabled coronary plaque analysis (AI-CPA) quantifies and stages atherosclerotic plaque for more personalized risk assessment insuspected CAD. Faculty will review how plaque staging aligns with current guidelines, highlight one-year DECIDE study data comparing AI-CPA + CCTA vs. CCTA alone, and translate findings into patient-specific management. Attendees will gain practical insight into applying Heartflow plaque analysis in daily patient care.
This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee or Scientific Sessions Programming.
Moderator:
Dr. Leslee Shaw
Icahn School of Medicine at Mount Sinai
New York, NY
Speakers:
Dr. Seth Martin
Corewell Health
Troy, MI
Dr. Michael Gallagher
Johns Hopkins University School of Medicine
Baltimore, MD
Hands-On Training Workshops & Onsite Experience
Practical, interactive workflows with AHA Faculty and a Heartflow specialist
AHA Simulation Zone
Practical, interactive workflows with AHA Faculty and a Heartflow specialist.
Saturday, November 7, 2026
9:30-11:00am | 1:30-3:00pm | 3:00-4:30pm
Sunday, November 8, 2025
9:30-11:00am | 3:00-4:30pm
Monday, November 9, 2025
9:30-11:00am | 1:30-3:00pm
Arrive early to secure your spot, or stop by the Heartflow booth to have an account manager walk you to the zone.
In-Booth Experience: Visit us at Booth #711 to Get Hands-On Experience
Innovation Hub:
-
Explore next generation pipeline technology in risk stratification and plaque tracking.
-
The technology shown is under development and is not available for commercial use. It has not been cleared by the FDA and is not for sale in the United States or elsewhere.
Customer 1:1 Meetings:
-
Let us know some dates and times that work for you and what you would like to discuss, and we will match you with the best leadership team member. Use the "Contact Us" form below.
Meet our Dedicated Team:
-
Get hands-on with the User Interface; a Heartflow account manager will guide you through patient case studies.